Beyond funding, McKesson Amplify also will provide resources, strategic support and other tools to help state pharmacy ...

International Assets Investment Management LLC lessened its stake in McKesson Co. (NYSE:MCK – Free Report) by 99.8% in the ...

McKesson (NYSE:MCK – Free Report) had its price objective decreased by Bank of America from $680.00 to $650.00 in a report ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Following the completion of the transaction, Core Ventures will be part of the Oncology platform, and financial results will be reported within McKesson’s U.S. Pharmaceutical segment.

McKesson has launched McKesson Amplify, a strategic initiative intended to help protect critical pharmacy services and elevate the pharmacy profession by strengthening the voice of the ...

McKesson Corporation MCK, on Tuesday, announced the completion of its earlier-announced divestiture of Canada-based Rexall ...

McKesson, a massive company that distributes pharmaceuticals and medical supplies, is laying off 83 employees and permanently closing a medical-surgical distribution center in Rogers, the company ...

The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma ...

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains ...

McKesson Amplify is intended to help protect critical pharmacy services and elevate the profession by strengthening the voice ...